Z-1477-2026 Class II Ongoing

Recalled by Olympus Corporation Of The Americas — Center Valley, PA

FDA device recall Z-1477-2026 was initiated by Olympus Corporation Of The Americas on Nov 14, 2025 and is designated Class II. Reason for recall: Ongoing investigations identified additional instances of the device Generator remaining in a blinking phase waiting to recognize the transducer. Damage to the transducer plug and/or generator… The recall status is ongoing. Affected quantity: 602 units.

Recall details

Product Type
Devices
Report Date
Mar 11, 2026
Initiation Date
Nov 14, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
602 units

Product description

Brand Name: ShockPulse-SE Lithotripsy System SPL-SR Product Name: ShockPulse-SE Lithotripsy System - Reusable Probes Model/Catalog Number: SPL-SR Product Description: The ShockPulse Lithotripsy System is an electromechanical device capable of fragmenting calculi and aspirating stone debris. The ShockPulse transducer is a reusable device that requires cleaning and steam sterilization prior to use in order to generate both low-frequency mechanical impacts and high-frequency ultrasonic energy that quickly disintegrates stones.

Reason for recall

Ongoing investigations identified additional instances of the device Generator remaining in a blinking phase waiting to recognize the transducer. Damage to the transducer plug and/or generator receptacle may cause these issues.

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Canada, Mexico, Bolivia, Chile, India, China, EU, Singapore, Australia, Korea, and Japan.

Code information

Model/Catalog Number: SPL-SR; UDI: 00821925043824; Serial Numbers: All;

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1477-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1477-2026. Report a data issue: hello@regdatalab.com.